Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
<p>Abstract</p> <p>Background</p> <p>The chromodomain, helicase DNA-binding protein 5 (CHD5) is a potential tumor suppressor gene located on chromosome 1p36, a region recurrently deleted in high risk neuroblastoma (NB). Previous data have shown that <it>CHD5 </...
Main Authors: | Galván Patricia, Perez-Atayde Antonio R, Casala Carla, George Rani E, Kieran Mark W, Cheung Nai-Kong V, Ríos José, Gershon Timothy R, Suñol Mariona, Rodríguez Eva, Mayol Gemma, Garcia Idoia, de Torres Carmen, Mora Jaume, Lavarino Cinzia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/277 |
Similar Items
-
DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis.
by: Gemma Mayol, et al.
Published: (2012-01-01) -
Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.
by: Laia Masvidal, et al.
Published: (2013-01-01) -
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
by: Kushner Brian, et al.
Published: (2009-02-01) -
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
by: Soledad Gómez, et al.
Published: (2015-09-01) -
Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
by: Beleta Helena, et al.
Published: (2009-02-01)